{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:33:53Z","timestamp":1793831633717,"version":"4.6.1"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"51","license":[{"start":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T00:00:00Z","timestamp":1640217600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Thyroid dysfunction increases the prevalence of metabolic syndrome. However, the link between thyroid hormones and metabolic syndrome remains debatable, and the effect of sex on their relationship is not completely understood. To elucidate the relationship of thyroid hormones with metabolic syndrome and its components according to sex in euthyroid individuals in South Korea. Adult participants who underwent thyroid tests at our institution between January 2015 and December 2018 and had thyroid-stimulating hormone (TSH; 0.270\u20134.200\u200a\u03bcIU\/mL) and free thyroxine (FT4; 0.93\u20131.70\u200ang\/dL) levels in the normal range were included. After correcting for age and body mass index, multiple linear regression was performed to assess the association of TSH and FT4 with metabolic syndrome and its components, and logistic regression was performed to estimate the risk of developing metabolic syndrome and its components according to different thyroid hormone quartiles. We included 12,478 men and 7,575 women in this study. The prevalence of metabolic syndrome was 9.68%. In men, TSH was positively associated with blood pressure and triglycerides, and the odds ratio for high blood pressure and hypertriglyceridemia was approximately 1.3 times higher in the fourth quartile than in the first quartile. FT4 associated positively with waist circumference, and a high odds ratio for abdominal obesity in the fourth quartile was observed in both men (odds ratio [OR], 1.239; 95% confidence interval [CI], 1.045\u20131.470) and women (OR, 1.302; 95% CI, 1.029\u20131.649). A negative association was found between FT4 and triglycerides, and concurrently, the odds ratios for hypertriglyceridemia were lower in the fourth quartile in both men (OR, 0.692; 95% CI, 0.619\u20130.774) and women (OR: 0.641; 95% CI: 0.512\u20130.803). In addition, a higher odds ratio for high blood pressure was observed in the fourth quartiles of FT4 and TSH in women. However, there was no association between TSH and FT4 levels and the onset of metabolic syndrome in either of the sexes. Serum TSH and FT4 levels were associated with different metabolic syndrome components in men and women, but there was no association with the onset of metabolic syndrome.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000028409","type":"journal-article","created":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T19:40:34Z","timestamp":1640288434000},"page":"e28409","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":17,"title":["Association between thyroid hormone and components of metabolic syndrome in euthyroid Korean adults"],"prefix":"10.1097","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5266-5627","authenticated-orcid":false,"given":"Kyung A.","family":"Shin","sequence":"first","affiliation":[{"name":"Clinical Laboratory Science, Shinsung University, Daehak-ro, Jeongmi-myeon, Dangjin-si, Chungcheongnam-do, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Jae","family":"Kim","sequence":"additional","affiliation":[{"name":"Medical Laboratory Science, Jeonju Kijeon University, Wansan-gu, Jeonju-si Jeollabuk-do, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,12,23]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1210\/er.2008-0024","article-title":"The metabolic syndrome","volume":"29","author":"Cornier","year":"2008","journal-title":"Endocr Rev"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12902-017-0215-1","article-title":"Thyroid function and metabolic syndrome in the population-based LifeLines cohort study","volume":"17","author":"Wolffenbuttel","year":"2017","journal-title":"BMC Endocr Disord"},{"key":"R3-20250504","article-title":"Exploring the association between thyroid-stimulating hormone and metabolic syndrome: a large population-based study","volume":"13","author":"Zhou","year":"2018","journal-title":"PLoS One"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"01","DOI":"10.1111\/obr.12229","article-title":"Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies","volume":"16","author":"O\u2019Neill","year":"2015","journal-title":"Obes Rev"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1080\/07370016.2015.992266","article-title":"Prevalence and associated factors of metabolic syndrome among South Korean adults","volume":"32","author":"Park","year":"2015","journal-title":"J Community Health Nurs"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"295","DOI":"10.5551\/jat.12.295","article-title":"The metabolic syndrome: a global public health problem and a new definition","volume":"12","author":"Zimmet","year":"2005","journal-title":"J Atheroscler Thromb"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"03","DOI":"10.1016\/j.cmrp.2017.11.010","article-title":"Study of thyroid dysfunction in metabolic syndrome and association with its components","volume":"8","author":"Saluja","year":"2018","journal-title":"Cur Med Res Prac"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1159\/000485996","article-title":"Metabolic syndrome in thyroid disease","volume":"49","author":"Iwen","year":"2018","journal-title":"Front Horm Res"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"03","DOI":"10.1186\/s40842-016-0021-0","article-title":"Thyroid dysfunction in metabolic syndrome patients and its relationship with components of metabolic syndrome","volume":"2","author":"Khatiwada","year":"2016","journal-title":"Clin Diabetes Endocrinol"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"01","DOI":"10.1016\/j.dsx.2017.08.001","article-title":"Relationship of metabolic syndrome and its components with thyroid dysfunction in Algerian patients","volume":"12","author":"Hamlaoui","year":"2018","journal-title":"Diabetes Metab Syndr"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/j.1365-2265.2009.03698.x","article-title":"A high normal TSH is associated with the metabolic syndrome","volume":"72","author":"Ruhla","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1089\/thy.2014.0103","article-title":"Serum free thyroxine concentration is associated with metabolic syndrome in euthyroid subjects","volume":"24","author":"Mehran","year":"2014","journal-title":"Thyroid"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1365-2265.2008.03304.x","article-title":"Relationship between serum free T4 (FT4) levels and metabolic syndrome (MS) and its components in healthy euthyroid subjects","volume":"70","author":"Kim","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1161\/ATVBAHA.107.151092","article-title":"Metabolic syndrome pandemic","volume":"28","author":"Grundy","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"09","DOI":"10.1186\/1472-6823-14-9","article-title":"The prevalence of metabolic syndrome and metabolically healthy obesity in Europe: a collaborative analysis of ten large cohort studies","volume":"14","author":"van Vliet-Ostaptchouk","year":"2014","journal-title":"BMC Endocr Disord"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.4158\/EP161260.OR","article-title":"The association of thyroid hormones and TSH with the metabolic syndrome in euthyroid Taiwanese individuals","volume":"22","author":"Huang","year":"2016","journal-title":"Endocr Pract"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1089\/thy.2017.0078","article-title":"Excessive iodine intake and thyrotropin reference interval: data from the Korean National Health and Nutrition Examination Survey","volume":"27","author":"Jeon","year":"2017","journal-title":"Thyroid"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3803\/EnM.2017.32.1.106","article-title":"Thyroid stimulating hormone reference range and prevalence of thyroid dysfunction in the Korean population: Korea National Health and Nutrition Examination Survey 2013 to 2015","volume":"32","author":"Kim","year":"2017","journal-title":"Endocrinol Metab (Seoul)"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/nyas.12374","article-title":"Thyroid hormone signaling in energy homeostasis and energy metabolism","volume":"1311","author":"McAninch","year":"2014","journal-title":"Ann N Y Acad Sci"},{"key":"R23-20250504","first-page":"1118","article-title":"Resting energy expenditure is sensitive to small dose changes in patients on chronic thyroid hormone replacement","volume":"82","author":"al-Adsani","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0002-9629(15)40631-7","article-title":"Blood volumes and renal function in overt and subclinical primary hypothyroidism","volume":"318","author":"Villabona","year":"1999","journal-title":"Am J Med Sci"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1530\/EJE-08-0797","article-title":"Studies of insulin resistance in patients with clinical and subclinical hypothyroidism","volume":"160","author":"Maratou","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1530\/EJE-10-0246","article-title":"Studies of insulin resistance in patients with clinical and subclinical hyperthyroidism","volume":"163","author":"Maratou","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"4683","DOI":"10.1210\/jc.2012-3849","article-title":"Thyroid function tests and mortality in aged hospitalized patients: a 7-year prospective observational study","volume":"98","author":"Iglesias","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1001\/jama.288.21.2709","article-title":"The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men","volume":"288","author":"Lakka","year":"2002","journal-title":"JAMA"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12902-019-0383-2","article-title":"Thyroid function, body mass index, and metabolic risk markers in euthyroid adults: a cohort study","volume":"19","author":"Xu","year":"2019","journal-title":"BMC Endocr Disord"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/j.1365-2265.2011.04328.x","article-title":"Thyroid function and prevalent and incident metabolic syndrome in older adults: the Health, Ageing and Body Composition Study","volume":"76","author":"Waring","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3803\/EnM.2016.31.2.311","article-title":"Triiodothyronine levels are independently associated with metabolic syndrome in euthyroid middle-aged subjects","volume":"31","author":"Kim","year":"2016","journal-title":"Endocrinol Metab (Seoul)"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1210\/jc.2006-1718","article-title":"Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects","volume":"92","author":"Roos","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12902-018-0256-0","article-title":"Association between thyroid hormones and the components of metabolic syndrome","volume":"18","author":"Jang","year":"2018","journal-title":"BMC Endocr Disord"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.maturitas.2009.01.007","article-title":"Thyroid stimulating hormone is associated with metabolic syndrome in euthyroid postmenopausal women","volume":"62","author":"Park","year":"2009","journal-title":"Maturitas"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1530\/EJE-10-0312","article-title":"TSH and free thyroxine concentrations are associated with differing metabolic markers in euthyroid subjects","volume":"163","author":"Garduno-Garcia Jde","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1055\/s-0042-121421","article-title":"Thyroid function in human obesity: underlying mechanisms","volume":"48","author":"Fontenelle","year":"2016","journal-title":"Horm Metab Res"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"152850","DOI":"10.4061\/2011\/152850","article-title":"Why can insulin resistance be a natural consequence of thyroid dysfunction?","volume":"2011","author":"Brenta","year":"2011","journal-title":"J Thyroid Res"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3389\/fphys.2014.00475","article-title":"New avenues for regulation of lipid metabolism by thyroid hormones and analogs","volume":"5","author":"Senese","year":"2014","journal-title":"Front Physiol"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1038\/sj.ijo.0801292","article-title":"Thyroid and lipid metabolism","volume":"24 Suppl 2","author":"Pucci","year":"2000","journal-title":"Int J Obes Relat Metab Disord"},{"key":"R40-20250504","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0140-6736(73)90250-X","article-title":"Triglyceride metabolism in thyroid disease","volume":"1","author":"Tulloch","year":"1973","journal-title":"Lancet"},{"key":"R41-20250504","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1677\/joe.0.1710193","article-title":"Thyroid function and aging: gender-related differences","volume":"171","author":"da Costa","year":"2001","journal-title":"J Endocrinol"},{"key":"R42-20250504","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s10654-007-9183-5","article-title":"Gender difference on the development of metabolic syndrome: a population-based study in Taiwan","volume":"22","author":"Hwang","year":"2007","journal-title":"Eur J Epidemiol"},{"key":"R43-20250504","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.2147\/DMSO.S204836","article-title":"Association between glycemic status and thyroid dysfunction in patients with type 2 diabetes mellitus","volume":"12","author":"Ogbonna","year":"2019","journal-title":"Diabetes Metab Syndr Obes"},{"key":"R44-20250504","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.2147\/DMSO.S260039","article-title":"Thyroid hormone changes in euthyroid patients with diabetes","volume":"13","author":"Qin","year":"2020","journal-title":"Diabetes Metab Syndr Obes"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000028409","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T06:08:09Z","timestamp":1746338889000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000028409"}},"subtitle":["A population-based study"],"short-title":[],"issued":{"date-parts":[[2021,12,23]]},"references-count":43,"journal-issue":{"issue":"51","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000028409","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,23]]},"assertion":[{"value":"2021-05-18","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-06","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}